Horizon Pharma plc Announces 2016 Net Sales and Adjusted EBITDA Guidance; Reviews 2020 Long-Range Plan
DUBLIN, IRELAND -- (Marketwired) -- 11/09/15 --
Full-Year 2016 Net Sales Guidance of $950 to $975 million
Full-Year 2016 Adjusted EBITDA Guidance of $460 to $475 million
2020 Long-Range Plan Net Sales Estimated to Exceed $2 billion
Long-Range Plan Estimates Orphan Business to Represent Approximately 60 percent of Net Sales in 2020
Viendo la cotización actual me cuadra perfectamente 1 share DEPO = 0,95 share HZNP.
Creo que el actual Consejo de DEPO tiene los días contados.
Se agradecen opiniones, puesto que voy casi all in en esta.
HZNP